Amkay Products Ltd

Amkay Products Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Amkay Products Ltd

₹ 66.9 -3.83%
31 May - close price
amkayproducts.com BSE - SME: 544169
About

Incorporated in October 2007, Amkay Products Limited is a company that produces and sells a wide range of healthcare products[1]

Key Points

Product Portfolio[1] Medical devices, disposables, face masks, alcohol swabs, lancet needles, nebulizers, pulse oximeters, surgeon caps, etc. used by healthcare centers, hospitals/clinics, nursing homes, and other such facilities across India.

Website BSE
  • Market Cap ₹ 57.9 Cr.
  • Current Price ₹ 66.9
  • High / Low ₹ 121 / 65.3
  • Stock P/E 22.0
  • Book Value ₹
  • Dividend Yield 0.00 %
  • ROCE 32.3 %
  • ROE 34.0 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 26.0%

Cons

  • Earnings include an other income of Rs.1.25 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Mar 2024
16.69
15.15
Operating Profit 1.54
OPM % 9.23%
0.76
Interest 0.28
Depreciation 0.30
Profit before tax 1.72
Tax % 23.26%
1.33
EPS in Rs 2.09
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
26.41 40.63 36.47 27.82 31.07
24.82 36.14 33.78 24.65 27.74
Operating Profit 1.59 4.49 2.69 3.17 3.33
OPM % 6.02% 11.05% 7.38% 11.39% 10.72%
0.04 0.10 0.29 0.38 1.25
Interest 0.47 0.24 0.41 0.50 0.52
Depreciation 0.52 0.51 0.54 0.71 0.56
Profit before tax 0.64 3.84 2.03 2.34 3.50
Tax % 25.00% 25.00% 28.08% 34.62% 24.86%
0.48 2.88 1.47 1.53 2.63
EPS in Rs 173.29 1,039.71 530.69 552.35 4.13
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: -9%
TTM: 12%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -3%
TTM: 101%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 26%
Last Year: 34%

Balance Sheet

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 0.28 0.28 0.28 0.28 6.36
Reserves 2.42 5.67 5.93 7.46 3.64
1.62 0.42 4.33 4.70 5.47
2.55 7.69 5.26 3.22 2.48
Total Liabilities 6.87 14.06 15.80 15.66 17.95
0.00 0.00 3.91 3.26 2.58
CWIP 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.40 2.79 3.62 3.24
6.87 13.66 9.10 8.78 12.13
Total Assets 6.87 14.06 15.80 15.66 17.95

Cash Flows

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0.00 0.00 -0.25 0.98
0.00 0.00 -3.07 -1.39
0.00 0.00 2.59 0.26
Net Cash Flow 0.00 0.00 -0.72 -0.15

Ratios

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 31.23 40.43 36.33 48.68
Inventory Days 4.54 4.18 28.03 52.66
Days Payable 41.76 82.57 64.42 50.24
Cash Conversion Cycle -5.98 -37.96 -0.06 51.10
Working Capital Days 10.78 -8.62 29.82 68.75
ROCE % 76.33% 28.86% 21.85%

Shareholding Pattern

Numbers in percentages

18 Recently
May 2024
73.43%
5.25%
6.28%
15.03%
No. of Shareholders 621

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

No data available.